3 ML icatibant 10 MG/ML Prefilled Syringe
- RxCUI
- 1148141
- RxNorm name
- 3 ML icatibant 10 MG/ML Prefilled Syringe
- Display name
- 3 ML icatibant 10 MG/ML Prefilled Syringe
- Full name
- 3 ML icatibant 10 MG/ML Prefilled Syringe
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:26
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Firazyr | ICATIBANT ACETATE | Takeda Pharmaceuticals America, Inc. | ed6657ca-ab68-477a-9968-e12dc928b540 | 2025-07-07 | Warnings, Adverse reactions | 1148141 |
| Icatibant | ICATIBANT | Alembic Pharmaceuticals Inc. | aeb5406c-9501-4f43-8134-5b02a7fa7451 | 2025-07-01 | Warnings, Adverse reactions | 1148141 |
| Icatibant | ICATIBANT | Alembic Pharmaceuticals Limited | 8c149392-d281-4311-880f-3be2b4752f40 | 2025-06-27 | Warnings, Adverse reactions | 1148141 |
| Icatibant | ICATIBANT | Hikma Pharmaceuticals USA Inc. | 94a53361-4eda-4e30-a153-44cd142983dd | 2024-04-25 | Warnings, Adverse reactions | 1148141 |
| Icatibant | ICATIBANT | Eugia US LLC | 56d5047e-3f99-4100-af4f-388870986ced | 2024-04-02 | Warnings, Adverse reactions | 1148141 |
| ICATIBANT | ICATIBANT | Cipla USA Inc. | ccbb5e50-ce56-4898-aa1a-f1c1f3d312f6 | 2024-02-16 | Warnings, Adverse reactions | 1148141 |
| SAJAZIR | ICATIBANT | Cycle Pharmaceuticals Ltd-Uk | 1756aca0-21a1-4898-8d6c-9666738db45c | 2024-02-16 | Warnings, Adverse reactions | 1148141 |
| Icatibant | ICATIBANT | Teva Pharmaceuticals USA, Inc. | 402a20e0-d1e2-4a24-ae1d-f2ff6d8fa7b3 | 2024-02-15 | Warnings, Adverse reactions | 1148141 |
| Icatibant | ICATIBANT | Fresenius Kabi USA, LLC | 52c12c15-c00b-4efc-952d-1425c907706a | 2023-11-08 | Warnings, Adverse reactions | 1148141 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| ed6657ca-ab68-477a-9968-e12dc928b540 | icatibant 30 MG in 3 ML Prefilled Syringe [PSN] · 3 ML icatibant 10 MG/ML Prefilled Syringe [SCD] · icatibant (as icatibant acetate) 30 MG per 3 ML Prefilled Syringe [SY] | 3 | 19 | These highlights do not include all the information needed to use FIRAZYR ® (icatibant) safely and effectively. See full prescribing information for FIRAZYR. FIRAZYR (icatibant) Injection, for subcutaneous use Initial U.S. Approval: 2011 | 20250707 |
| 94a53361-4eda-4e30-a153-44cd142983dd | icatibant 30 MG in 3 ML Prefilled Syringe [PSN] · 3 ML icatibant 10 MG/ML Prefilled Syringe [SCD] · icatibant (as icatibant acetate) 30 MG per 3 ML Prefilled Syringe [SY] | 3 | 19 | These highlights do not include all the information needed to use ICATIBANT INJECTION safely and effectively. See full prescribing information for ICATIBANT INJECTION. ICATIBANT injection, for subcutaneous use Initial U.S. Approval: 2011 | 20240425 |
| 402a20e0-d1e2-4a24-ae1d-f2ff6d8fa7b3 | icatibant 30 MG in 3 ML Prefilled Syringe [PSN] · 3 ML icatibant 10 MG/ML Prefilled Syringe [SCD] · icatibant (as icatibant acetate) 30 MG per 3 ML Prefilled Syringe [SY] | 3 | 9 | These highlights do not include all the information needed to use ICATIBANT INJECTION safely and effectively. See full prescribing information for ICATIBANT INJECTION . ICATIBANT injection, for subcutaneous use Initial U.S. Approval: 2011 | 20240215 |
| aeb5406c-9501-4f43-8134-5b02a7fa7451 | icatibant 30 MG in 3 ML Prefilled Syringe [PSN] · 3 ML icatibant 10 MG/ML Prefilled Syringe [SCD] · icatibant (as icatibant acetate) 30 MG per 3 ML Prefilled Syringe [SY] | 3 | 8 | These highlights do not include all the information needed to use ICATIBANT INJECTION safely and effectively. See full prescribing information for ICATIBANT INJECTION. ICATIBANT injection, for subcutaneous use Initial U.S. Approval: 2011 | 20250701 |
| ccbb5e50-ce56-4898-aa1a-f1c1f3d312f6 | icatibant 30 MG in 3 ML Prefilled Syringe [PSN] · 3 ML icatibant 10 MG/ML Prefilled Syringe [SCD] · icatibant (as icatibant acetate) 30 MG per 3 ML Prefilled Syringe [SY] | 3 | 6 | These highlights do not include all the information needed to use ICATIBANT INJECTION safely and effectively. See full prescribing information for ICATIBANT INJECTION. ICATIBANT injection, for subcutaneous use Initial U.S. Approval: 2011 | 20240216 |
| 1756aca0-21a1-4898-8d6c-9666738db45c | icatibant 30 MG in 3 ML Prefilled Syringe [PSN] · 3 ML icatibant 10 MG/ML Prefilled Syringe [SCD] · icatibant (as icatibant acetate) 30 MG per 3 ML Prefilled Syringe [SY] | 3 | 5 | These highlights do not include all the information needed to use SAJAZIR™ (icatibant) safely and effectively. See full prescribing information for SAJAZIR™. SAJAZIR™ (icatibant) injection, for subcutaneous use Initial U.S. Approval: 2011 | 20240216 |
| 52c12c15-c00b-4efc-952d-1425c907706a | icatibant 30 MG in 3 ML Prefilled Syringe [PSN] · 3 ML icatibant 10 MG/ML Prefilled Syringe [SCD] · icatibant (as icatibant acetate) 30 MG per 3 ML Prefilled Syringe [SY] | 3 | 4 | These highlights do not include all the information needed to use ICATIBANT INJECTION safely and effectively. See full prescribing information for ICATIBANT INJECTION. ICATIBANT injection, for subcutaneous use Initial U.S. Approval: 2011 | 20231108 |
| 56d5047e-3f99-4100-af4f-388870986ced | icatibant 30 MG in 3 ML Prefilled Syringe [PSN] · 3 ML icatibant 10 MG/ML Prefilled Syringe [SCD] · icatibant (as icatibant acetate) 30 MG per 3 ML Prefilled Syringe [SY] | 3 | 2 | These highlights do not include all the information needed to use ICATIBANT INJECTION safely and effectively. See full prescribing information for ICATIBANT INJECTION. ICATIBANT injection, for subcutaneous use Initial U.S. Approval: 2011 | 20240402 |
| 8c149392-d281-4311-880f-3be2b4752f40 | icatibant 30 MG in 3 ML Prefilled Syringe [PSN] · 3 ML icatibant 10 MG/ML Prefilled Syringe [SCD] · icatibant (as icatibant acetate) 30 MG per 3 ML Prefilled Syringe [SY] | 3 | 1 | These highlights do not include all the information needed to use ICATIBANT INJECTION safely and effectively. See full prescribing information for ICATIBANT INJECTION. ICATIBANT injection, for subcutaneous use Initial U.S. Approval: 2011 | 20250627 |